Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey L Uy

Showing results (21-30 of 146) with videos related to

Pageof 15
Sort By:
Blood|July 3, 2009
BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cellsPablo Ramirez, Michael P Rettig, Geoffrey L Uy, et al.
Blood Advances|June 8, 2019
Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614)Jun Yin, Betsy LaPlant, Geoffrey L Uy, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 29, 2016
Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantationMichael Slade, Scott Goldsmith, Rizwan Romee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2012
Plasmacytoma-like post-transplantation lymphoproliferative disease occurring in a cardiac allograft: a case report and review of the literatureTzu-Fei Wang, Jonathan L Klein, Pamela K Woodard, et al.
Plos One|October 12, 2012
Expression and function of PML-RARA in the hematopoietic progenitor cells of Ctsg-PML-RARA miceLukas D Wartman, John S Welch, Geoffrey L Uy, et al.
Clinical Lymphoma & Myeloma|January 12, 2008
Bortezomib inhibits osteoclast activity in patients with multiple myelomaGeoffrey L Uy, Rachna Trivedi, Shachar Peles, et al.
International Journal of Hematology|September 20, 2020
Phase 1 dose escalation trial of volasertib in combination with decitabine in patients with acute myeloid leukemiaJorge Cortes, Nikolai Podoltsev, Hagop Kantarjian, et al.
Investigational New Drugs|November 18, 2019
A phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumorsAlbiruni R Abdul Razak, Wilson H Miller, Geoffrey L Uy, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 31, 2019
A Phase I Study of the Safety and Feasibility of Bortezomib in Combination With G-CSF for Stem Cell Mobilization in Patients With Multiple MyelomaArmin Ghobadi, Mark A Fiala, Michael Rettig, et al.
Blood Advances|November 27, 2024
Deficit accumulation frailty index and treatment tolerability in AML: data from CALGB 11001 and 11002 (Alliance)Catherine Lai, Minji Lee, Olivia Bobek, et al.
Pageof 15

Showing results (21-30 of 146) with videos related to

Sort By:
Pageof 15
Blood|July 3, 2009
BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cellsPablo Ramirez, Michael P Rettig, Geoffrey L Uy, et al.
Blood Advances|June 8, 2019
Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614)Jun Yin, Betsy LaPlant, Geoffrey L Uy, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 29, 2016
Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantationMichael Slade, Scott Goldsmith, Rizwan Romee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2012
Plasmacytoma-like post-transplantation lymphoproliferative disease occurring in a cardiac allograft: a case report and review of the literatureTzu-Fei Wang, Jonathan L Klein, Pamela K Woodard, et al.
Plos One|October 12, 2012
Expression and function of PML-RARA in the hematopoietic progenitor cells of Ctsg-PML-RARA miceLukas D Wartman, John S Welch, Geoffrey L Uy, et al.
Clinical Lymphoma & Myeloma|January 12, 2008
Bortezomib inhibits osteoclast activity in patients with multiple myelomaGeoffrey L Uy, Rachna Trivedi, Shachar Peles, et al.
International Journal of Hematology|September 20, 2020
Phase 1 dose escalation trial of volasertib in combination with decitabine in patients with acute myeloid leukemiaJorge Cortes, Nikolai Podoltsev, Hagop Kantarjian, et al.
Investigational New Drugs|November 18, 2019
A phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumorsAlbiruni R Abdul Razak, Wilson H Miller, Geoffrey L Uy, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 31, 2019
A Phase I Study of the Safety and Feasibility of Bortezomib in Combination With G-CSF for Stem Cell Mobilization in Patients With Multiple MyelomaArmin Ghobadi, Mark A Fiala, Michael Rettig, et al.
Blood Advances|November 27, 2024
Deficit accumulation frailty index and treatment tolerability in AML: data from CALGB 11001 and 11002 (Alliance)Catherine Lai, Minji Lee, Olivia Bobek, et al.
Pageof 15